Hemochromatosis mutations in the general population: Iron overload progression rate

Blood

Volumn 103, Issue 8, 2004, Pages 2914-2919

  Andersen, Rolf Værn ^b   Tybjærg Hansen, Anne ^b   Appleyard, Merete ^b   Birgens, Henrik ^b   Nordestgaard, Børge Grønne ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; TRANSFERRIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; FEMALE; FERRITIN BLOOD LEVEL; GENE; GENOTYPE; HEMOCHROMATOSIS; HFE GENE; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 1842579593     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-10-3564     Document Type: Article

References (26)

1. Beutler E, Bothwell TH, Charlton RW, Motulsky AG. Hereditary hemochromatosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 8th ed. New York, NY: McGraw-Hill; 2001:3127-3161.
2. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
3. Barton JC, Bertoli LF. Hemochromatosis: the genetic disorder of the twenty-first century. Nat Med. 1996;2:394-395.
4. Smith BN, Kantrowitz W, Grace ND, et al. Prevalence of hereditary hemochromatosis in a Massachusetts corporation: is Celtic origin a risk factor? Hepatology. 1997;25:1439-1446.
5. Edwards CQ, Griffen LM, Ajioka RS, Kushner JP. Screening for hemochromatosis: phenotype versus genotype. Semin Hematol. 1998;35:72-76.
6. Adams PC. Population screening for hemochromatosis. Hepatology. 1999;29:1324-1327.
7. Beuller E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet. 2002;359:211-218.
8. Åsberg A, Hveem K, Kruger Ø, Bjerve KS. Persons with screening-detected haemochromatosis: as healthy as the general population? Scand J Gastroenterol. 2002;37:719-724.
9. Jackson HA, Carter K, Darke C, et al. HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol. 2001;114:474-484.
10. Åsberg A, Hveem K, Thorstensen K, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol. 2001;36:1108-1115.
11. Beaumont C, Simon M, Fauchet R, et al. Serum ferritin as a possible marker of the hemochromatosis allele. N Engl J Med. 1979;301:169-174.
12. Meyer T, Baynes R, Bothwell T, et al. Phenotypic expression of the HLA linked iron-loading gene in males over the age of 40 years: a population study using serial serum lerritin estimations. J Intern Med. 1990;227:397-406.
13. Mitman N, Clausen JO, Jordal R. Iron status in young Danish men and women: a population survey comprising 548 individuals. Ann Hematol. 1995;70:215-221.
14. Bassett ML, Halliday JW, Ferris RA, Powell LW. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology. 1984;87:628-633.
15. Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes in patients attending a health appraisal clinic. Ann Intern Med. 2000;133:329-337.
16. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med. 1999;341:718-724.
17. Crawford DH, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology. 1998;114:1003-1008.
18. Bradley LA, Haddow JE, Palomaki GE. Population screening for haemochromatosis: a unifying analysis of published intervention trials. J Med Screen. 1996;9:178-184.
19. Bulaj ZJ, Ajioka RS, Phillips JD, et al. Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med. 2000;343:1529-1535.
20. Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, et al. Prevalence of hereditary haemochromatosis in late-onset type I diabetes mellitus: a retrospective study. Lancet. 2001;358:1405-1409.
21. Schnohr P, Jensen G, Lange P, Scharling H, Appleyard M. The Copenhagen City Heart Study: tables with data from the third examination 1991-1994. Eur Heart J Suppl. 2001;3:1-83.
22. SPSS Base 8.0 for Windows User's Guide and SPSS Inferactive Graphics 8.0. Chicago, IL: SPSS Inc; 1998.
23. Guyader D, Jacquelinet C, Moirand R, et al. Non-invasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology. 1998;115:929-936.
24. Bothwell TH, MacPhail AP. Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects. Semin Hematol. 1998;35:55-71.
25. Willis G, Wimperis JZ, Lonsdale R, et al. Incidence of liver disease in people with HFE mutations. Gut. 2000;46:401-404.
26. Merryweather-Clarke AT, Simonsen H, Shearman JD, et al. A retrospective anonymous pilot study in screening newborns for HFE mutalions in Scandinavian populations. Hum Metat. 1999;13:154-159.